Patient Affordability Introduction

This page includes resources for health care professionals to share with patients using ZYTIGA® (abiraterone acetate) and their family members and caregivers. Please click on any of the links below to get more detailed information.

Janssen Prescription Assistance for ZYTIGA® (abiraterone acetate). This page contains information about prescription assistance programs sponsored by relevant Janssen Pharmaceutical Companies as well as up-to-date information about independent foundations that may have available funding to help minimize drug costs for ZYTIGA®.

ZytigaOne® Instant Savings Program Flashcard. Eligible patients may qualify for instant savings on their private insurance co-pay, deductible, and co-insurance medication costs for ZYTIGA® (abiraterone acetate) through the ZytigaOne® Instant Savings Program. If a patient qualifies and activates the ZytigaOne® Instant Savings Card, the patient will pay no more than $10 per month for ZYTIGA®. The program is subject to a $12,000 annual program benefit, 12 months after activation or 12 doses, whichever comes first. To activate your Instant Savings Card or to enroll in the Instant Savings Program, click here. To learn more about the program, including eligibility and restrictions, click here.

Johnson & Johnson Patient Assistance Foundation. Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is committed to providing access to medicines for uninsured individuals who lack the financial resources to pay for them. If your patient needs ZYTIGA® (abiraterone acetate), and is uninsured and unable to pay for their medicine, please have them contact a JJPAF program specialist at 1-800-652-6227 9 AM to 6 PM ET or visit the foundation website at to see if they might qualify for assistance.

October 7, 2014